24,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
12 °P sammeln
  • Broschiertes Buch

Obstructive Sleep Apnea Syndrome (OSAS) is defined as the interruption of airflow for more than 10 seconds in individuals who have five or more episodes every hour of sleep during the night. It is the most serious occurrence of upper airway obstructive disorders which, in addition to disrupting sleep, can cause anxiety, irritability, insulin resistance, increase the risk of accidents and the development of cardiovascular diseases, contributing to a reduction in quality of life. Among patients with OSAS, the use of benzodiazepines is common. These drugs have been shown to induce sleep and…mehr

Produktbeschreibung
Obstructive Sleep Apnea Syndrome (OSAS) is defined as the interruption of airflow for more than 10 seconds in individuals who have five or more episodes every hour of sleep during the night. It is the most serious occurrence of upper airway obstructive disorders which, in addition to disrupting sleep, can cause anxiety, irritability, insulin resistance, increase the risk of accidents and the development of cardiovascular diseases, contributing to a reduction in quality of life. Among patients with OSAS, the use of benzodiazepines is common. These drugs have been shown to induce sleep and reduce muscle tone. This study aimed to assess respiratory muscle strength in individuals with OSAS, as well as its relationship with benzodiazepines.
Autorenporträt
Graduated in Physiotherapy from Centro Universitário de Formiga, specialist in Hospital Physiotherapy from Hospital Israelita Albert Einstein (HIAE), Master of Science from the University of São Paulo (USP). He has laboratory experience in Human Anatomy and Physiology, Pulmonary Pathology and clinical experience in Cardiopulmonary Physiotherapy and Intensive Care.